A Study to Determine the Effect of Multiple Doses of BMS-955176 on the Electrocardiograph of Healthy Subjects
Status:
Terminated
Trial end date:
2016-10-14
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the effect of multiple doses of BMS-955176 on the QT
interval corrected with Fridericia's method (QTcF) in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb ViiV Healthcare
Collaborator:
GlaxoSmithKline
Treatments:
BMS-955176 Moxifloxacin Norgestimate, ethinyl estradiol drug combination